A Study to Assess Efficacy and Safety of JNJ-77242113 Compared to Placebo and Ustekinumab in Participants With Moderate to Severe Plaque Psoriasis
Clinical trial NCT06934226 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06934226
- Sponsor
- Janssen Research & Development, LLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-15
- Primary completion
- 2025-11-17
- Enrollment
- 752
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.